Additional Information
Book Details
Abstract
Hypertension continues to be one of the leading causes of morbidity and mortality, significantly increasing the risk of stroke, myocardial infarction, heart failure and renal failure. It is one of the key risk factors in the metabolic syndrome, increasingly common in Western society. With such a complex aetiology, information on current antihypertensive therapy is extremely varied and dense. This new book presents a series of in-depth reviews by leading experts, bringing together in one volume the most up-to-date view on how antihypertensive therapies should be administered in a wide range of clinical settings. Incorporating the latest research on pharmacological action, clinical trials and treatment strategies, this book is one of the most complete references on antihypertensive therapy currently available and is an essential purchase for any specialist working with hypertensive patients.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Executive summary | |||
1. Introduction | |||
2. The inadequacies of energy access finance | |||
3. A bottom-up approach to estimating national technology mix and financing requirements | |||
4. Togo | |||
5. Kenya | |||
6. Bangladesh | |||
7. National implications of community-driven planning | |||
8. A how-to guide for quickly and sustainably scaling energy finance and delivery | |||
9. Conclusions and recommendations |